Ventas is a healthcare facility REIT company located in Illinois, United States, which is part of the Real Estate sector, and is traded under the ticker VTR on the NYSE exchange.
Ventas stock last closed at $45.55, up 0.57% from the previous day, and has increased 3.1% in one year. It has overperformed other stocks in the REIT - Healthcare Facilities industry by 0.08 percentage points. Ventas stock is currently +15.81% from its 52-week low of $39.33, and -14.3% from its 52-week high of $53.15.
At the moment, there are 402.38M shares of VTR outstanding. The market value of VTR is $18.33B. In the last 24 hours, 1.37M VTR shares were traded.
How to Buy Ventas Stock
Wondering how to invest in Ventas stock? Here's how.
Decide where to buy Ventas stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Ventas stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Choose your payment method and add your info.
Analyze Ventas stock: The Ventas ticker symbol is VTR. Is Ventas stock a good investment? Should you buy shares of VTR? How do VTR's underlying business fundamentals look? Do top analysts think Ventas is a good buy? Why has VTR's stock price moved recently? (Hint: Our stock market research website can help you evaluate if VTR is a good stock to buy).
Execute your VTR purchase: Decide if you will purchase VTR shares at the current market price or use a limit order to buy VTR stock at a specific price.
Get updates on your VTR investment: Create a watchlist to monitor your position in Ventas shares.
Step 1: Decide where to buy Ventas stock
You will need a brokerage account to access the NYSE market and buy VTR stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Tech to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you can invest in VTR today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Ventas stock
Once you have identified the best place to buy Ventas stock, it's very important to research their stock prior to buying, so you can wrap your head around the risk as well as the upside.
Ventas stock at a glance
VTR Price
$45.55
1w %
2.31%
1y %
3.1%
5y %
-26.6%
P/E
4,555x
P/B
1.87x
P/S
4.18x
PEG
7.31x
Revenue
$4.38B
Earnings
$4.83M
Fore. Rev. Growth
4.02%
Fore. Earn. Growth
622.86%
Market Cap
$18.33B
Next Earnings
N/A
Next Dividend
N/A
Ventas Overview
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on VTR's stock page.
Is VTR stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge VTR's true value.
Using relative valuations methods:
VTR could be overvalued based on its P/E ratio of 4,555x, relative to REIT - Healthcare Facilities industry P/E ratio of 857.84x
VTR could be overvalued based on its P/B ratio of 1.87x, relative to REIT - Healthcare Facilities industry P/B ratio of 1.51x
VTR may be overvalued based on its PEG ratio of 7.31x
VTR profit margin has gone up from -1.1% to 0.1% in the past year.
Negative Health Checks:
Total VTR debt is higher than 5 years ago, relative to shareholder equity.
VTR's operating cash flow of $1.11B allows it to safely service it's debt of $13.59B.
VTR earnings of $530.63M is not enough to cover its interest payments.
VTR has a relatively high debt to equity ratio of 1.51.
Is VTR stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 11 sell side analysts who track VTR, the consensus analyst rating on Ventas is a Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent VTR Analyst Recommendations
Michael Mueller, a bottom 6% analyst from JP Morgan maintains VTR with a hold rating and lowers their VTR price target from $49.00 to $48.00, on Aug 30, 2023.
Joshua Dennerlein, a bottom 14% analyst from Bank of America downgrades VTR to a hold rating and lowers their VTR price target from $54.00 to $48.00, on Aug 11, 2023.
Michael Carroll, a bottom 14% analyst from RBC Capital maintains VTR with a buy rating and lowers their VTR price target from $54.00 to $53.00, on Aug 9, 2023.
Steven Valiquette, a bottom 14% analyst from Barclays maintains VTR with a strong buy rating and maintains their VTR price target from $55.00 to $55.00, on Aug 4, 2023.
Nicholas Joseph, a top 35% analyst from Citigroup reiterates VTR with a strong buy rating and maintains their VTR price target from $52.00 to $52.00, on Jun 27, 2023.
You can dive deeper into what analysts are projecting on the Ventas stock forecast page.
VTR Trading Indicators
SMA10
44.83
SMA20
44.05
SMA50
42.85
SMA100
44.05
SMA200
44.99
MACD
0.7
MACD Signal
0.55
MACD Histogram
0.14
RSI
63.63
Stochastic %K
93.26
Stochastic %D
86.56
StochRSI %K
99.73
StochRSI %D
93.61
Is VTR Making Money?
Last year, VTR earnings were $4.83M. In the past 5 year, VTR's earnings have gone up by -65.65% per year. This was slower than the REIT - Healthcare Facilities industry average of -20.24%.
Last year, VTR revenue was $4.38B. Over the past five year, VTR's revenue has gone up by 3.36% per year. This was slower than the REIT - Healthcare Facilities industry average of 5.61%.
Ventas pays a dividend of 3.95%, compared to the REIT - Healthcare Facilities industry's average dividend yield of 7.48%. If you owned $1,000 of VTR stock, you would have received $39.52 last year.
Ventas dividend payments have not consistently grown over the past decade and have not remained stable.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your VTR purchase
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually sufficient.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you require more help with buying stocks on eToro, watch the how to video below:
As of Nov 28, 2023, it costs $45.55 to buy one share of Ventas stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.22 shares of VTR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.